CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Metronidazole Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2022-01-13. Latest FDA row update: 2026-10-02.
FDA lists 4 package records, with companies: Baxter Healthcare, Baxter Healthcare Corporation, Gland Pharma Limited, Hospira, Inc., InfoRLife SA, Sagent Pharmaceuticals, Sun Pharmaceutical Industries, Inc.. Package NDCs: 0338-1055-48, 0409-0152-24, 25021-131-82, 47335-993-01.
FDA shortage reason: Discontinuation of the manufacture of the drug; Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Baxter Healthcare | 0338-1055-48 | Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48) | Available | 2026-10-02 |
| Gland Pharma Limited | 47335-993-01 | Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01) | Unavailable | 2026-07-22 |
| InfoRLife SA | 0409-0152-24 | Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24) | Limited Availability | 2026-08-18 |
| InfoRLife SA | 25021-131-82 | Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82) | Limited Availability | 2026-08-18 |
Source facts
Grouped generic ingredient: Metronidazole Injection · 4 package records
Therapeutic categories: Anti-Infective
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.